BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9094031)

  • 21. The Utility of Serum Alpha-fetoprotein for Monitoring for Relapse of Alpha-fetoprotein-Positive Hepatoblastoma.
    Davini M; Hastings C; Feusner J
    J Pediatr Hematol Oncol; 2024 May; 46(4):206-210. PubMed ID: 38551915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coexisting Infantile Hepatic Hemangioma and Hepatoblastoma in a Neonate: A Case Report.
    Zhang SH; Chen GY; Wei L
    Int J Surg Pathol; 2023 Jun; 31(4):485-490. PubMed ID: 37097887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal hamartomas of the liver may be associated with increased serum alpha foetoprotein concentrations and mimic hepatoblastomas.
    Boman F; Bossard C; Fabre M; Diab N; Bonnevalle M; Boccon-Gibod L
    Eur J Pediatr Surg; 2004 Feb; 14(1):63-6. PubMed ID: 15024683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relapse surveillance in AFP-positive hepatoblastoma: re-evaluating the role of imaging.
    Rojas Y; Guillerman RP; Zhang W; Vasudevan SA; Nuchtern JG; Thompson PA
    Pediatr Radiol; 2014 Oct; 44(10):1275-80. PubMed ID: 24839140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical differentiation of yolk sac-type alpha-fetoprotein from hepatic-type alpha-fetoprotein.
    Okamoto T
    Acta Pathol Jpn; 1989 Jan; 39(1):51-4. PubMed ID: 2469293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum alpha-fetoprotein subfractions identified by Ricinus communis agglutinin I in hepatic malignancies, yolk sac tumor, benign hepatic diseases, and fetal stage.
    Ishiguro T; Takahashi Y
    Dis Markers; 1989; 7(4):239-45. PubMed ID: 2479498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the structure of alpha-fetoprotein and its clinical use in pediatric surgery.
    Tsuchida Y; Kaneko M; Saito S; Endo Y
    J Pediatr Surg; 1985 Jun; 20(3):260-5. PubMed ID: 2409260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pretransplant trends in α-fetoprotein levels as a predictor of recurrence after living donor liver transplantation for unresectable hepatoblastoma: A single-institution experience.
    Isono K; Ohya Y; Lee KJ; Hashimoto S; Kadohisa M; Sakisaka M; Uto K; Hayashida S; Yamamoto H; Yamamoto H; Sugawara Y; Inomata Y
    Pediatr Transplant; 2018 Aug; 22(5):e13221. PubMed ID: 29761829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Alpha1-fetoprotein: physiology, pathology and diagnosis especially in childhood (author's transl)].
    Knöpfle G; Becker M; Rotthauwe HW
    Klin Padiatr; 1977 Jul; 189(4):207-26. PubMed ID: 70546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical type distinction of alpha-fetoprotein in various alpha-fetoprotein-secreting tumors.
    Okamoto T; Hirabayashi K; Ishiguro T
    Jpn J Cancer Res; 1993 Apr; 84(4):360-4. PubMed ID: 7685750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.
    de la Motte Rouge T; Pautier P; Genestie C; Rey A; Gouy S; Leary A; Haie-Meder C; Kerbrat P; Culine S; Fizazi K; Lhommé C
    Gynecol Oncol; 2016 Sep; 142(3):452-7. PubMed ID: 27401840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glypican 3 as a Serum Marker for Hepatoblastoma.
    Zhou S; O'Gorman MR; Yang F; Andresen K; Wang L
    Sci Rep; 2017 Apr; 7():45932. PubMed ID: 28378832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The prognostic significance of serum alpha 1-fetoprotein in children and adolescents with malignant extracranial non-testicular germ cell tumors].
    Calaminus G; Vesterling-Hörner D; Bökkerink JP; Gadner H; Günther G; Haas HJ; Jürgens H; Teske C; Göbel U
    Klin Padiatr; 1991; 203(4):246-50. PubMed ID: 1719268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Half-life of alpha-fetoprotein in patients with a teratoma, endodermal sinus tumor, or hepatoblastoma.
    Walhof CM; Van Sonderen L; Voûte PA; Delemarre JF
    Pediatr Hematol Oncol; 1988; 5(3):217-27. PubMed ID: 2484653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythrina cristagalli lectin-reactive alpha-fetoprotein-E2: a marker of hepatocellular carcinoma and other malignancies.
    Kamei M; Misawa A; Arai J; Kamakura K; Taketa K
    Int J Biol Markers; 1998; 13(1):24-9. PubMed ID: 9681296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hepatoblastoma cells producing alpha-fetoprotein: morphometric, immunohistochemical and electron microscopic studies].
    Shabanov MA; Liubimova OE; Raĭkhlin NT; Adne ZhZh
    Arkh Patol; 1987; 49(12):9-16. PubMed ID: 2451492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoelectrophoretic differentiation of alpha-fetoprotein in disorders with elevated serum alpha-fetoprotein levels or during pregnancy.
    Chen RJ; Chen CK; Chang DY; Chow SN; Huang SC; Hsieh CY; Lin MC; Hsu HC
    Acta Oncol; 1995; 34(7):931-5. PubMed ID: 7492383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly enhanced fucosylation of alpha-fetoprotein in patients with germ cell tumor.
    Aoyagi Y; Suzuki Y; Igarashi K; Yokota T; Mori S; Suda T; Naitoh A; Isemura M; Asakura H
    Cancer; 1993 Jul; 72(2):615-8. PubMed ID: 7686444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-fetoprotein reaction to Pisum sativum agglutinin in differentiation of benign liver diseases from hepatocellular carcinoma.
    Yin ZF; Tu ZX; Cui ZF; Wu MC
    Chin Med J (Engl); 1993 Aug; 106(8):615-8. PubMed ID: 7693403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioimmunoassay of alpha-fetoprotein in children with primary intracranial tumors.
    Shinomiya Y; Toya S; Iwata T; Hosoda Y
    Childs Brain; 1979; 5(5):450-8. PubMed ID: 89937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.